Drug profile · INN
atropine sulfate hydrate
RYJUSEA MINI
atropine sulfate hydrate (RYJUSEA MINI) is a muscarinic acetylcholine receptor m1 antagonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — atropine sulfate hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
atropine sulfate hydrate (RYJUSEA MINI) is a muscarinic acetylcholine receptor m1 antagonist.
Key facts
INN atropine sulfate hydrate
Brand RYJUSEA MINI
Mechanism Muscarinic acetylcholine receptor M1 antagonist
Target Muscarinic acetylcholine receptor M1
Mechanism of action
Muscarinic acetylcholine receptor M1 antagonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is atropine sulfate hydrate?
atropine sulfate hydrate (RYJUSEA MINI) is a muscarinic acetylcholine receptor m1 antagonist.
What is the brand name for atropine sulfate hydrate?
RYJUSEA MINI is a marketed brand name for atropine sulfate hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.